AI-powered pen sized dental diagnostics.
Dental health professionals lacked tools to identify early stage structural damage, such as micro cracks, failing fillings, or early implant instability, without invasive procedures. InnerView uses Quantitative Percussion Diagnostics with AI to fill this critical diagnostic gap.
RKS studied clinical workflows, observing dentists, hygienists, and patients, to detect emotional stress and inefficiencies in existing diagnostics. Applying Psycho‑Aesthetics®, we positioned InnerView in the enriched/empathy quadrant: accurate, wearable, reassuring diagnostics that build patient confidence.
How We Used Psycho-Aesthetics™ to Identify Unique Opportunities in the Project.
Using our proprietary Psycho-Aesthetics® 2.0 framework, we conducted in-depth interviews and ethnographic observation in diverse lab settings. We identified key emotional and usability pain points — such as intimidation with complex interfaces, workspace clutter, and trust in precision. These insights guided both the form and interface strategy, ensuring approachability and confidence in operation.
We shaped a pen like wireless hand piece optimized for ergonomic grip, balance, and intuitive operation. A discreet base station and serviceable form reinforce its integration into busy operatory setups.
The clinician facing app provides real time visuals and trendlines. Clear indicators of tooth integrity and alarming colors facilitate rapid interpretation, reducing cognitive load during exams.
RKS facilitated integration of mechanical tapping mechanisms, sensors, AI firmware, and wireless protocols. Collaborating with Perimetrics, we delivered prototypes, guided FEA, sourced vendors, and supported FDA cleared manufacturing.
Device completed FDA clearance
InnerView AI demonstrates RKS Design’s mastery in fusing human centered design, clinical insight, and engineering precision. We delivered an ergonomic, FDA cleared diagnostic device that enhances dentist confidence, improves patient care, and builds a scalable commercial platform grounded in trust, efficiency, and innovation.
Backed by 29 clinical studies and 78 patents
$14 B+ dental diagnostics opportunity; forecasted $275 M in annual revenues by 2029 with razor‑blade consumables & SaaS.
FDA-cleared in September 2023 for tooth/implant mobility diagnostics. Commercial launch scheduled for early 2024, with broader crack detection by 2025.
Strategy
Welcome to a world of design and innovation
If this is not the case, then click the button below to start it
